Structures by: Boldyreva E. V.
Total: 418
Tolazamide
C14H21N3O3S
Acta Crystallographica Section C (2019) 75, 5 598-608
a=6.2738(3)Å b=9.0824(4)Å c=13.3414(5)Å
α=79.449(4)° β=87.415(3)° γ=86.013(4)°
Tolazamide
C14H21N3O3S
Acta Crystallographica Section C (2019) 75, 5 598-608
a=6.2433(2)Å b=9.0724(4)Å c=13.3119(5)Å
α=79.359(4)° β=87.461(3)° γ=85.933(3)°
Tolazamide
C14H21N3O3S
Acta Crystallographica Section C (2019) 75, 5 598-608
a=6.3939(3)Å b=8.9809(4)Å c=13.5213(7)Å
α=82.129(4)° β=85.602(4)° γ=85.341(4)°
Chlorpropamide, α^II^-form
C10H13ClN2O3S
Acta Crystallographica Section B (2013) 69, 1 77-85
a=25.602(3)Å b=4.6340(2)Å c=8.8525(4)Å
α=99.109(4)° β=90.00° γ=90.00°
DL-serine
C3H7NO3
Acta Crystallographica Section B (2012) 68, 3 275-286
a=4.8307(12)Å b=8.956(2)Å c=10.175(10)Å
α=90.00° β=101.33(5)° γ=90.00°
DL-serine
C3H7NO3
Acta Crystallographica Section B (2012) 68, 3 275-286
a=4.7576(6)Å b=8.7046(6)Å c=9.785(11)Å
α=90.00° β=102.25(4)° γ=90.00°
DL-serine
C3H7NO3
Acta Crystallographica Section B (2012) 68, 3 275-286
a=4.7926(5)Å b=8.7932(5)Å c=9.907(9)Å
α=90.00° β=102.14(4)° γ=90.00°
L-serine
C3H7NO3
Acta Crystallographica Section B (2012) 68, 3 275-286
a=5.5885(14)Å b=8.542(9)Å c=9.146(4)Å
α=90.00° β=90.00° γ=90.00°
L-serine
C3H7NO3
Acta Crystallographica Section B (2012) 68, 3 275-286
a=5.514(2)Å b=8.396(11)Å c=8.868(6)Å
α=90.00° β=90.00° γ=90.00°
Glutaric acid--glycine (1/1)
C5H8O4,C2H5NO2
Acta Crystallographica Section B (2012) 68, 3 287-296
a=4.9022(7)Å b=20.901(3)Å c=10.2730(15)Å
α=90.00° β=114.600(10)° γ=90.00°
Glutaric acid--glycine (1/1)
C5H8O4,C2H5NO2
Acta Crystallographica Section B (2012) 68, 3 287-296
a=4.8952(6)Å b=20.151(3)Å c=10.1585(13)Å
α=85.518(11)° β=113.088(9)° γ=88.264(11)°
DL-alanine
C3H7NO2
Acta Crystallographica Section B (2012) 68, 4 412-423
a=11.572(4)Å b=5.567(5)Å c=5.6710(11)Å
α=90.00° β=90.00° γ=90.00°
Nitropentaammine Co(III) chloride
H15CoN6O22,2(Cl1)
Acta Crystallographica Section C (1998) 54, 10 1378-1383
a=10.3140(10)Å b=8.5870(10)Å c=10.7100(10)Å
α=90.00° β=94.950(10)° γ=90.00°
<i>L</i>-Serinium semi-maleate
C3H8NO3,C4H3O4
Acta Crystallographica Section C (2013) 69, 5 517-521
a=6.9527(11)Å b=6.5631(10)Å c=10.4284(19)Å
α=90.00° β=97.094(14)° γ=90.00°
N,N-dimethylglycine
C4H9NO2
Crystal Growth & Design (2014) 14, 4 1851
a=11.1668(4)Å b=9.8988(5)Å c=18.6714(10)Å
α=91.313(5)° β=90.00° γ=90.00°
N,N-dimethylglycine
C4H9NO2
Crystal Growth & Design (2014) 14, 4 1851
a=11.1619(4)Å b=9.8870(4)Å c=18.6616(10)Å
α=91.493(4)° β=90.00° γ=90.00°
Furosemide 1,4-dioxane solvate
C12H11Cl1N2O5S1,C4H8O2
Crystal Growth & Design (2014) 14, 2 513
a=7.9759(5)Å b=10.6923(7)Å c=10.9369(7)Å
α=86.247(5)° β=79.053(5)° γ=80.548(5)°
Na2 C2 O4
C2Na2O4
Zeitschrift fuer Kristallographie (149,1979-) (2006) 221, 186-197
a=3.482Å b=5.262Å c=10.432Å
α=90° β=93.08° γ=90°